These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 9537580)

  • 1. Isolation and analysis of two strongly transforming isoforms of the Epstein-Barr-Virus(EBV)-encoded latent membrane protein-1 (LMP1) from a single Hodgkin's lymphoma.
    Mehl AM; Fischer N; Rowe M; Hartmann F; Daus H; Trümper L; Pfreundschuh M; Müller-Lantzsch N; Grässer FA
    Int J Cancer; 1998 Apr; 76(2):194-200. PubMed ID: 9537580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of the LMP1 oncoprotein in the EBV negative Hodgkin's disease cell line L-428 is associated with Reed-Sternberg cell morphology.
    Knecht H; McQuain C; Martin J; Rothenberger S; Drexler HG; Berger C; Bachmann E; Kittler EL; Odermatt BF; Quesenberry PJ
    Oncogene; 1996 Sep; 13(5):947-53. PubMed ID: 8806684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular analysis of latent membrane protein 1 in patients with Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in Japan.
    Tabata YHibi S; Teramura T; Kuriyama K; Yagi T; Todo S; Sawada T; Imashuku S
    Leuk Lymphoma; 2000 Jul; 38(3-4):373-80. PubMed ID: 10830744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nucleotide sequences and functions of the Epstein-Barr virus latent membrane protein 1 genes isolated from salivary gland lymphoepithelial carcinomas.
    Jen KY; Higuchi M; Cheng J; Li J; Wu LY; Li YF; Lin HL; Chen Z; Gurtsevitch V; Fujii M; Saku T
    Virus Genes; 2005 Mar; 30(2):223-35. PubMed ID: 15744579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of major histocompatibility complex class I, TAP expression, and LMP2 epitope sequence in Epstein-Barr virus-positive Hodgkin's disease.
    Murray PG; Constandinou CM; Crocker J; Young LS; Ambinder RF
    Blood; 1998 Oct; 92(7):2477-83. PubMed ID: 9746788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A deletion mutant of the LMP1 oncogene of Epstein-Barr virus is associated with evolution of angioimmunoblastic lymphadenopathy into B immunoblastic lymphoma.
    Knecht H; Martius F; Bachmann E; Hoffman T; Zimmermann DR; Rothenberger S; Sandvej K; Wegmann W; Hurwitz N; Odermatt BF
    Leukemia; 1995 Mar; 9(3):458-65. PubMed ID: 7885044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of functional differences between prototype Epstein-Barr virus-encoded LMP1 and a nasopharyngeal carcinoma-derived LMP1 in human epithelial cells.
    Dawson CW; Eliopoulos AG; Blake SM; Barker R; Young LS
    Virology; 2000 Jun; 272(1):204-17. PubMed ID: 10873763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The 30-base-pair deletion in Chinese variants of the Epstein-Barr virus LMP1 gene is not the major effector of functional differences between variant LMP1 genes in human lymphocytes.
    Johnson RJ; Stack M; Hazlewood SA; Jones M; Blackmore CG; Hu LF; Rowe M
    J Virol; 1998 May; 72(5):4038-48. PubMed ID: 9557692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deletion of Epstein-Barr virus latent membrane protein 1 gene in United States and Brazilian Hodgkin's disease and reactive lymphoid tissue: high frequency of a 30-bp deletion.
    Hayashi K; Chen WG; Chen YY; Bacchi MM; Bacchi CE; Alvarenga M; Abreu ES; Chang KL; Weiss LM
    Hum Pathol; 1997 Dec; 28(12):1408-14. PubMed ID: 9416698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional analysis of different LMP1 proteins isolated from Epstein-Barr virus-positive carriers.
    Fischer N; Kopper B; Graf N; Schlehofer JR; Grässer FA; Mueller-Lantzsch N
    Virus Res; 1999 Mar; 60(1):41-54. PubMed ID: 10225273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coexpression of major histocompatibility complex class I and LMP1 in Epstein-Barr virus-positive Hodgkin's lymphoma in a pediatric age group.
    Aybar A; Krause JR
    Microsc Res Tech; 2005 Nov; 68(3-4):247-9. PubMed ID: 16276512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [LMP1 gene variants of Epstein-Barr virus in patients with some lymphoproliferative malignancies].
    Gurtsevich VE; Goncharova EV; Shcherbak LN; Kovrigina AM; Falaleeva NA; Iakovleva LS; Stepina VN; Popova AA; Sterlikova AA; Osmanov EA; Pavlish OA
    Vopr Virusol; 2006; 51(2):35-9. PubMed ID: 16756177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr virus-encoded LMP1 and CD40 mediate IL-6 production in epithelial cells via an NF-kappaB pathway involving TNF receptor-associated factors.
    Eliopoulos AG; Stack M; Dawson CW; Kaye KM; Hodgkin L; Sihota S; Rowe M; Young LS
    Oncogene; 1997 Jun; 14(24):2899-916. PubMed ID: 9205097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural variability of the carboxy-terminus of Epstein-Barr virus encoded latent membrane protein 1 gene in Hodgkin's lymphomas.
    Guiretti DM; Chabay PA; Valva P; Stefanoff CG; Barros MH; De Matteo E; Renault IZ; Preciado MV; Hassan R
    J Med Virol; 2007 Nov; 79(11):1730-22. PubMed ID: 17854036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Functional analysis of Epstein-Barr virus latent membrane proteins (LMP1) in patients with limphoproliferative disorders].
    Smirnova KV; Diduk SV; Gurtsevich VÉ
    Biomed Khim; 2011; 57(1):114-26. PubMed ID: 21516783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The transmembrane domains of the EBV-encoded latent membrane protein 1 (LMP1) variant CAO regulate enhanced signalling activity.
    Blake SM; Eliopoulos AG; Dawson CW; Young LS
    Virology; 2001 Apr; 282(2):278-87. PubMed ID: 11289810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific latent membrane protein 1 gene sequences in type 1 and type 2 Epstein-Barr virus from nasopharyngeal carcinoma in Hong Kong.
    Cheung ST; Leung SF; Lo KW; Chiu KW; Tam JS; Fok TF; Johnson PJ; Lee JC; Huang DP
    Int J Cancer; 1998 May; 76(3):399-406. PubMed ID: 9579578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr virus and Hodgkin's disease: transcriptional analysis of virus latency in the malignant cells.
    Deacon EM; Pallesen G; Niedobitek G; Crocker J; Brooks L; Rickinson AB; Young LS
    J Exp Med; 1993 Feb; 177(2):339-49. PubMed ID: 8381153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deletions within the LMP1 oncogene of Epstein-Barr virus are clustered in Hodgkin's disease and identical to those observed in nasopharyngeal carcinoma.
    Knecht H; Bachmann E; Brousset P; Sandvej K; Nadal D; Bachmann F; Odermatt BF; Delsol G; Pallesen G
    Blood; 1993 Nov; 82(10):2937-42. PubMed ID: 8219183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative analysis identifies conserved tumor necrosis factor receptor-associated factor 3 binding sites in the human and simian Epstein-Barr virus oncogene LMP1.
    Franken M; Devergne O; Rosenzweig M; Annis B; Kieff E; Wang F
    J Virol; 1996 Nov; 70(11):7819-26. PubMed ID: 8892903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.